Bsenexus Terminal Open in Bsenexus App →
BOARD_MEETING BSE: 500660

GlaxoSmithKline Pharmaceuticals Ltd

GlaxoSmithKline Pharmaceuticals Ltd - 500660 - Board Meeting Intimation for To Consider, Approve And Take On Record The Un-Audited Financial Results For The Second Quarter & Half Year Ended 30Th September 2026.

Filing Details / Description
Glaxosmithkline Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/11/2026 ,inter alia, to consider and approve As per attachment
🔗 Related Announcements 5 Disclosures
Union Bank of India BOARD_MEETING
Union Bank of India - 532477 - Board Meeting Intimation for Notice Of Meeting Of Board Of Directors Of The Bank Scheduled On Monday, October 19, 2026
Laurus Labs Ltd BOARD_MEETING
Laurus Labs Ltd - 540222 - Board Meeting Intimation for Consideration Of The Un-Audited Financial Results Of The Company For The Quarter And Half-Year Ended September 30, 2026 And Payment Of Interim Dividend For FY 2026-27
Adani Enterprises Ltd BOARD_MEETING
Adani Enterprises Ltd - 512599 - Board Meeting Intimation for To Consider And Approve The Unaudited Financial Results Of The Company For The Quarter And Half Year Ended September 30, 2026.
Chembond Chemicals Ltd BOARD_MEETING
Chembond Chemicals Ltd - 544450 - Board Meeting Intimation for Approval Of Un-Audited Standalone And Consolidated Financial Results For The Quarter/Half Year Ended 30 September 2026
Gujarat State Fertilizers & Chemicals Ltd BOARD_MEETING
Gujarat State Fertilizers & Chemicals Ltd - 500690 - Board Meeting Intimation for Consideration Of Unaudited Financial Results For The Quarter And Half Year Ended 30Th September, 2026 And Closure Of Trading Window
📄 View Official BSE Filing (PDF) ↗ Explore Live BSE Corporate Disclosures on Bsenexus →